Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandan HealthcareNSE:CHANDAN -2.02%18 Return-on-Tangible-Asset is 6.75% as of Dec. 2025, which is 24% below its 10-year median of 8.91. GuruFocus rates NSE:CHANDAN with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, Chandan Healthcare ranks better than 70.75% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Chandan Healthcare's annualizedNet Income for the quarter that ended in Dec. 2025 was ₹182 Mil. Chandan Healthcare's average total tangible assets for the quarter that ended in Dec. 2025 was ₹2,687 Mil. Therefore, Chandan Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 6.75%.
The historical rank and industry rank for Chandan Healthcare's Return-on-Tangible-Asset or its related term are showing as below:
NSE:CHANDAN'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -1.44 Med: 8.91 Max: 15.72
Current: 4.95
During the past 4 years, Chandan Healthcare's highest Return-on-Tangible-Asset was 15.72%. The lowest was -1.44%. And the median was 8.91%.
NSE:CHANDAN's Return-on-Tangible-Asset is ranked better than 70.75% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.02
vs NSE:CHANDAN: 4.95
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Chandan Healthcare Return-on-Tangible-Asset Related Terms
Chandan Healthcare Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Chandan Healthcare's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CHANDAN vs TMO, DHR, IDXX: Return-on-Tangible-Asset Comparison
For the Diagnostics & Research subindustry, Chandan Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandan Healthcare Return-on-Tangible-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chandan Healthcare's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Chandan Healthcare's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 6.75% mean?
Chandan Healthcare (NSE:CHANDAN) has a Return-on-Tangible-Asset of 6.75% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Chandan Healthcare and its competitors. This is 24% below median its historical median of 8.91. According to the industry distribution chart, Chandan Healthcare ranks #62 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 29.2%.
Is Chandan Healthcare's Return-on-Tangible-Asset too high?
Chandan Healthcare's current Return-on-Tangible-Asset of 6.75% is 24% below median its 10-year median of 8.91. Based on the distribution chart, Chandan Healthcare ranks #62 out of 212 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Chandan Healthcare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Return-on-Tangible-Asset compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Chandan Healthcare ranks #62 out of 212 companies for Return-on-Tangible-Asset. This puts Chandan Healthcare in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Diagnostics & Research company?
A good Return-on-Tangible-Asset depends on the Medical Diagnostics & Research industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Chandan Healthcare and its competitors. Chandan Healthcare's current Return-on-Tangible-Asset is 6.75%, which is 24% below median its own 10-year median of 8.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Return-on-Tangible-Asset of 6.75%. The current Return-on-Tangible-Asset is 6.75%, which is 24% below median its 10-year median of 8.91. Chandan Healthcare's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Return-on-Tangible-Asset is 6.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
18GF Score
Get the complete analysis for NSE:CHANDAN
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CHANDAN has been successfully added to your 
